Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19037106 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR AUTOMATED ASSESSMENT OF ASEPTIC TECHNIQUE OF COMPOUNDING IN A COMPOUNDING HOOD | January 2025 | January 2026 | Allow | 11 | 1 | 1 | No | No |
| 19012608 | PREDICTING TOXICITY OF MOLECULES | January 2025 | December 2025 | Abandon | 11 | 1 | 0 | No | No |
| 18878959 | MULTI-INSTANCE GPU-BASED SYSTEM FOR DISCOVERING DRUG CANDIDATE | December 2024 | August 2025 | Allow | 8 | 1 | 0 | No | No |
| 18945348 | APPLICATION OF GENE MARKERS IN MULTI-CANCER EARLY DETECTION, METHOD FOR CONSTRUCTING EARLY DETECTION MODEL, AND DETECTION DEVICE | November 2024 | February 2026 | Allow | 15 | 1 | 1 | Yes | No |
| 18886100 | METHODS AND TOOLS FOR PREDICTING CARDIOMETABOLIC HEALTH BY COMBINING BLOOD T2 PARAMETERS WITH OTHER MEASURES | September 2024 | March 2026 | Allow | 18 | 3 | 1 | Yes | No |
| 18824130 | METHOD FOR QUANTITATIVELY ESTIMATING POTASSIUM DEMAND OF REGIONAL CORN PLANTS DURING KEY GROWTH STAGES | September 2024 | February 2026 | Abandon | 18 | 2 | 0 | No | No |
| 18507755 | METHOD AND APPARATUS FOR DETERMINING COPY NUMBER VARIATION PROFILE USING READ DEPTH CORRECTION IN WHOLE GENOME SEQUENCING | November 2023 | November 2025 | Allow | 24 | 3 | 1 | Yes | No |
| 18364554 | Classifier Apparatus With Decision Support Tool | August 2023 | June 2025 | Allow | 22 | 1 | 0 | Yes | No |
| 18356209 | MARKERS FOR PREDICTING POSSIBLITIES OF SUBJECTS WITH DIABETES AND USE THEREOF | July 2023 | October 2025 | Abandon | 26 | 2 | 2 | No | No |
| 18347986 | COMPUTATIONAL MODELING OF LOSS OF FUNCTION BASED ON ALLELIC FREQUENCY | July 2023 | March 2025 | Allow | 20 | 1 | 0 | No | No |
| 18331411 | PREDICTING THE METABOLIC CONDITION OF A CELL CULTURE | June 2023 | September 2025 | Allow | 27 | 2 | 0 | No | No |
| 18301249 | MARKERS FOR PREDICTING POSSIBILITIES OF SUBJECTS WITH DIABETES AND USE THEREOF | April 2023 | October 2025 | Abandon | 30 | 2 | 0 | No | No |
| 17757464 | METHOD FOR THE QUALITATIVE EVALUATION OF REAL-TIME PCR DATA | August 2022 | November 2025 | Allow | 41 | 4 | 0 | Yes | No |
| 17594585 | METHOD OF ALIGNING STRINGS OF CHARACTERS REPRESENTING GENOMIC DATA AND RELATED HARDWARE DEVICE | October 2021 | November 2025 | Allow | 49 | 1 | 0 | No | No |
| 17482135 | Methods and System for the Reconstruction of Drug Response and Disease Networks and Uses Thereof | September 2021 | October 2024 | Allow | 37 | 2 | 0 | No | No |
| 17593240 | METHOD AND SYSTEM FOR MAPPING READ SEQUENCES USING A PANGENOME REFERENCE | September 2021 | April 2025 | Allow | 43 | 1 | 0 | No | No |
| 17434550 | Amelioration Based on Detection of Biological Cells or Biological Substances | August 2021 | December 2025 | Abandon | 52 | 0 | 1 | No | No |
| 17399162 | DATA PROCESSING METHOD, DATA PROCESSING DEVICE, AND DATA PROCESSING SYSTEM | August 2021 | October 2025 | Allow | 50 | 1 | 0 | Yes | No |
| 17423138 | ANALYSIS METHOD OF LITHIUM COMPOSITE OXIDE, POSITIVE ELECTRODE ACTIVE MATERIAL, AND SECONDARY BATTERY | July 2021 | October 2025 | Abandon | 51 | 1 | 0 | No | No |
| 17351884 | ASSOCIATING PEDIGREE SCORES AND SIMILARITY SCORES FOR PLANT FEATURE PREDICTION | June 2021 | July 2025 | Abandon | 48 | 3 | 0 | Yes | No |
| 17288476 | SYSTEM AND METHOD FOR DETERMINING DEAMIDATION AND IMMUNOGENICITY OF POLYPEPTIDES | April 2021 | March 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17232056 | ARTIFICIAL INTELLIGENCE-BASED ANALYSIS OF PROTEIN THREE-DIMENSIONAL (3D) STRUCTURES | April 2021 | September 2024 | Allow | 41 | 3 | 0 | Yes | No |
| 17231972 | SYSTEMS AND METHODS FOR IDENTIFYING DIFFERENTIAL ACCESSIBILITY OF GENE REGULATORY ELEMENTS AT SINGLE CELL RESOLUTION | April 2021 | November 2025 | Abandon | 55 | 4 | 0 | Yes | No |
| 17273577 | MICROBIOME-BASED TRACKING SYSTEM AND METHODS RELATING THERETO | March 2021 | December 2024 | Abandon | 45 | 2 | 1 | No | No |
| 17191914 | SYSTEMS AND METHODS FOR CANCER CONDITION DETERMINATION USING AUTOENCODERS | March 2021 | January 2026 | Allow | 59 | 4 | 1 | Yes | No |
| 17184451 | GENETIC AND GENEALOGICAL ANALYSIS FOR IDENTIFICATION OF BIRTH LOCATION AND SURNAME INFORMATION | February 2021 | January 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17171768 | Dropout Detection in Continuous Analyte Monitoring Data During Data Excursions | February 2021 | June 2025 | Allow | 52 | 3 | 0 | Yes | No |
| 17265642 | Visual Representations of Peptide Sequences | February 2021 | April 2025 | Allow | 51 | 2 | 0 | Yes | No |
| 17263340 | REDUCING NOISE IN SEQUENCING DATA | January 2021 | September 2025 | Abandon | 55 | 2 | 1 | No | No |
| 17263201 | A METHOD FOR IDENTIFYING INTERMEDIATES | January 2021 | October 2025 | Allow | 57 | 3 | 0 | No | No |
| 17151936 | DEVELOPMENT OF NOVEL AUTOMATED SCREENING METHOD FOR DETECTION OF FVIII INHIBITORS | January 2021 | April 2025 | Allow | 51 | 1 | 1 | No | No |
| 17251706 | COMPOSITIONS AND METHODS FOR CELLULAR PHENOTYPE ASSESSMENT OF A SAMPLE USING CONFINED VOLUME ARRAYS | December 2020 | December 2025 | Allow | 60 | 3 | 0 | No | No |
| 17251293 | METHODS FOR DETECTING VARIANTS IN NEXT-GENERATION SEQUENCING GENOMIC DATA | December 2020 | December 2025 | Allow | 60 | 4 | 0 | Yes | No |
| 17106519 | METHODS AND SYSTEMS FOR DETERMINING THE PHYSICAL STATUS OF A SUBJECT | November 2020 | October 2025 | Allow | 59 | 4 | 0 | Yes | No |
| 17058795 | Method For Machine Learning To Find Patterns In Ensembles Of Biological Sequences Based On Biophysical Properties | November 2020 | August 2025 | Abandon | 57 | 4 | 0 | No | No |
| 17101912 | Topology-Driven Completion of Chemical Data | November 2020 | November 2025 | Allow | 59 | 5 | 0 | Yes | No |
| 16950845 | TECHNIQUES FOR DATA-ENABLED DRUG DISCOVERY | November 2020 | December 2025 | Allow | 60 | 4 | 0 | Yes | No |
| 17095970 | ANTIBODY SELECTION APPARATUS AND METHODS | November 2020 | June 2025 | Allow | 55 | 3 | 0 | Yes | No |
| 17050030 | METHOD FOR PREDICTING THE MELTING TEMPERATURE OF OLIGONUCLEOTIDE | October 2020 | May 2025 | Allow | 55 | 3 | 0 | No | No |
| 17048062 | A THREE-PROTEIN PROTEOMIC BIOMARKER FOR PROSPECTIVE DETERMINATION OF RISK FOR DEVELOPMENT OF ACTIVE TUBERCULOSIS | October 2020 | December 2024 | Abandon | 50 | 1 | 1 | No | No |
| 17047320 | ULTRA-SENSITIVE DETECTION OF CANCER BY ALGORITHMIC ANALYSIS | October 2020 | June 2025 | Abandon | 56 | 3 | 0 | Yes | No |
| 17039826 | DEEP LEARNING BASED VARIANT CALLING USING MACHINE LEARNING | September 2020 | August 2025 | Allow | 58 | 6 | 0 | Yes | No |
| 17043693 | METHOD FOR DETERMINING ANDROGEN AND ANTI-ANDROGEN EFFECTS ON SUBSTANCES | September 2020 | February 2025 | Abandon | 53 | 2 | 0 | No | No |
| 17043210 | METHOD OF SYNTHESIZING A RADIOPHARMACEUTICAL | September 2020 | December 2025 | Allow | 60 | 4 | 0 | Yes | No |
| 17041836 | Methods for Predicting Genomic Variation Effects on Gene Transcription | September 2020 | August 2024 | Allow | 47 | 2 | 0 | Yes | No |
| 17029280 | INTRA-HOSPITAL GENETIC PROFILE SIMILAR SEARCH | September 2020 | January 2026 | Abandon | 60 | 6 | 0 | Yes | No |
| 16975962 | Covariant Neural Network Architecture for Determining Atomic Potentials | August 2020 | November 2024 | Abandon | 51 | 2 | 0 | No | No |
| 16976056 | ULTRA-SENSITIVE DETECTION OF CIRCULATING TUMOR DNA THROUGH GENOME-WIDE INTEGRATION | August 2020 | September 2024 | Abandon | 49 | 3 | 1 | Yes | No |
| 16985765 | PREDICTIVE MONITORING OF THE GLUCOSE-INSULIN ENDOCRINE METABOLIC REGULATORY SYSTEM | August 2020 | August 2024 | Allow | 49 | 3 | 0 | Yes | No |
| 16929585 | SELECTION OF ANTIBODIES / ANTIBODY FRAGMENTS | July 2020 | November 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 16919577 | IDENTIFICATION, CHARACTERIZATION, AND QUANTITATION OF CRISPR-INTRODUCED DOUBLE-STRANDED DNA BREAK REPAIRS | July 2020 | July 2024 | Allow | 48 | 4 | 0 | Yes | No |
| 16907786 | PREDICTING THE METABOLIC CONDITION OF A CELL CULTURE | June 2020 | January 2023 | Allow | 31 | 4 | 0 | Yes | No |
| 16771880 | METHODS FOR DETECTING VARIANTS IN NEXT-GENERATION SEQUENCING GENOMIC DATA | June 2020 | November 2025 | Allow | 60 | 4 | 0 | Yes | No |
| 16880021 | FILTERING ARTIFICIAL INTELLIGENCE DESIGNED MOLECULES FOR LABORATORY TESTING | May 2020 | January 2025 | Abandon | 56 | 4 | 0 | Yes | No |
| 16803680 | COMPUTATIONAL MODELING OF LOSS OF FUNCTION BASED ON ALLELIC FREQUENCY | February 2020 | March 2026 | Allow | 60 | 5 | 0 | Yes | No |
| 16696010 | ANALYSIS OF NANOPORE SIGNAL USING A MACHINE-LEARNING TECHNIQUE | November 2019 | November 2024 | Allow | 60 | 4 | 0 | Yes | No |
| 16610897 | MACHINE LEARNING ANALYSIS OF NANOPORE MEASUREMENTS | November 2019 | May 2025 | Allow | 60 | 3 | 0 | No | No |
| 16581706 | METHODS OF NORMALIZING AND CORRECTING RNA EXPRESSION DATA | September 2019 | February 2026 | Allow | 60 | 6 | 1 | Yes | No |
| 16511691 | METHODS OF ANALYZING CELLS | July 2019 | October 2025 | Abandon | 60 | 4 | 0 | No | No |
| 16429886 | COMPOSITIONS AND METHODS FOR IMPROVED CALIBRATION ACCURACY OF CREATININE/CREATINE SENSORS AND USES THEREOF | June 2019 | September 2025 | Allow | 60 | 4 | 0 | No | No |
| 16277216 | Correlation Method To Identify Relevant Genes For Personalized Treatment Of Complex Disease | February 2019 | February 2025 | Abandon | 60 | 4 | 0 | Yes | No |
| 16037045 | Multivariate Residual-Based Health Index for Human Health Monitoring | July 2018 | April 2025 | Allow | 60 | 5 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner LEVERETT, MARY CHANG works in Art Unit 1687 and has examined 49 patent applications in our dataset. With an allowance rate of 63.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 55 months.
Examiner LEVERETT, MARY CHANG's allowance rate of 63.3% places them in the 23% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LEVERETT, MARY CHANG receive 3.12 office actions before reaching final disposition. This places the examiner in the 89% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LEVERETT, MARY CHANG is 55 months. This places the examiner in the 2% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +30.9% benefit to allowance rate for applications examined by LEVERETT, MARY CHANG. This interview benefit is in the 79% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.3% of applications are subsequently allowed. This success rate is in the 32% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 22.7% of cases where such amendments are filed. This entry rate is in the 30% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 71% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.5% of allowed cases (in the 84% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.